Brainstorm Cell Therapeutics shares owned by Geode Capital Management
Quarter-by-quarter ownership of Brainstorm Cell Therapeutics (BCLI) shares owned by Geode Capital Management
from 13F filings
Historical chart of Geode Capital Management investment in Brainstorm Cell Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Brainstorm Cell Therapeutics held by Geode Capital Management consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Brainstorm Cell Therapeutics by Geode Capital Management
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2023-09-30 | $62k | 311k | 0.20 |
| 2023-06-30 | $568k | 276k | 2.06 |
| 2023-03-31 | $910k | 276k | 3.30 |
| 2022-12-31 | $448k | 274k | 1.64 |
| 2022-09-30 | $1.2M | 277k | 4.42 |
| 2022-06-30 | $761k | 276k | 2.76 |
| 2022-03-31 | $952k | 284k | 3.36 |
| 2021-12-31 | $1.1M | 278k | 4.00 |
| 2021-09-30 | $909k | 276k | 3.30 |
| 2021-06-30 | $1.0M | 265k | 3.80 |
| 2021-03-31 | $1.8M | 478k | 3.83 |
| 2020-12-31 | $1.8M | 406k | 4.52 |
| 2020-09-30 | $6.8M | 400k | 16.92 |
| 2020-06-30 | $4.4M | 394k | 11.21 |
| 2020-03-31 | $786k | 170k | 4.63 |
| 2019-12-31 | $613k | 143k | 4.28 |
| 2019-09-30 | $559k | 143k | 3.90 |
| 2019-06-30 | $521k | 132k | 3.95 |
| 2019-03-31 | $456k | 105k | 4.33 |
| 2018-12-31 | $373k | 105k | 3.54 |
| 2018-09-30 | $402k | 105k | 3.82 |
| 2018-06-30 | $410k | 105k | 3.89 |
| 2018-03-31 | $269k | 86k | 3.14 |
| 2017-12-31 | $335k | 86k | 3.91 |
| 2017-09-30 | $353k | 86k | 4.12 |
| 2017-06-30 | $356k | 86k | 4.15 |
| 2017-03-31 | $311k | 73k | 4.24 |
| 2016-12-31 | $155k | 61k | 2.53 |
| 2016-09-30 | $146k | 61k | 2.38 |
| 2016-06-30 | $147k | 61k | 2.40 |
| 2016-03-31 | $163k | 61k | 2.66 |
| 2015-12-31 | $175k | 61k | 2.86 |
| 2015-09-30 | $140k | 61k | 2.29 |
| 2015-06-30 | $221k | 61k | 3.61 |
| 2015-03-31 | $272k | 61k | 4.44 |
| 2014-12-31 | $82k | 17k | 4.76 |